Literature DB >> 22138141

Biochemical characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime imaging microscopy.

Jesung Park1, Paritosh Pande, Sebina Shrestha, Fred Clubb, Brian E Applegate, Javier A Jo.   

Abstract

OBJECTIVE: To investigate the potential of endogenous multispectral fluorescence lifetime imaging microscopy (FLIM) for biochemical characterization of human coronary atherosclerotic plaques.
METHODS: Endogenous multispectral FLIM imaging was performed on the lumen of 58 segments of postmortem human coronary artery. The fluorescence was separated into three emission bands targeting the three main arterial endogenous fluorophores (390±20 nm for collagen, 452±22.5 nm for elastin, and 550±20 for lipids). The fluorescence normalized intensity and average lifetime from each emission band was used to classify each pixel of an image as either "High-Collagen", "High-Lipids" or "Low-Collagen/Lipids" via multiclass Fisher's linear discriminant analysis.
RESULTS: Classification of plaques as either "High-Collagen", "High-Lipids" or "Low-Collagen/Lipids" based on the endogenous multispectral FLIM was achieved with a sensitivity/specificity of 96/98%, 89/99%, and 99/99%, respectively, where histopathology served as the gold standard.
CONCLUSION: The endogenous multispectral FLIM approach we have taken, which can readily be adapted for in vivo intravascular catheter based imaging, is capable of reliably identifying plaques with high content of either collagen or lipids.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138141      PMCID: PMC3264694          DOI: 10.1016/j.atherosclerosis.2011.10.034

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  27 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques.

Authors:  Jennifer Phipps; Yinghua Sun; Ramez Saroufeem; Nisa Hatami; Michael C Fishbein; Laura Marcu
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

3.  Multimodal characterization of compositional, structural and functional features of human atherosclerotic plaques.

Authors:  Yang Sun; Abhijit J Chaudhari; Matthew Lam; Hongtao Xie; Diego R Yankelevich; Jennifer Phipps; Jing Liu; Michael C Fishbein; Jonathan M Cannata; K Kirk Shung; Laura Marcu
Journal:  Biomed Opt Express       Date:  2011-07-19       Impact factor: 3.732

4.  Virtual histology: does it add anything?

Authors:  Gaku Nakazawa; Aloke V Finn; Renu Virmani
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

5.  Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging.

Authors:  Eric Larose; Yerem Yeghiazarians; Peter Libby; E Kent Yucel; Masanori Aikawa; Daniel F Kacher; Elena Aikawa; Scott Kinlay; Frederick J Schoen; Andrew P Selwyn; Peter Ganz
Journal:  Circulation       Date:  2005-10-03       Impact factor: 29.690

6.  Laguerre-based method for analysis of time-resolved fluorescence data: application to in-vivo characterization and diagnosis of atherosclerotic lesions.

Authors:  Javier A Jo; Qiyin Fang; Thanassis Papaioannou; J Dennis Baker; Amir H Dorafshar; Todd Reil; Jian-Hua Qiao; Michael C Fishbein; Julie A Freischlag; Laura Marcu
Journal:  J Biomed Opt       Date:  2006 Mar-Apr       Impact factor: 3.170

7.  Detection of rupture-prone atherosclerotic plaques by time-resolved laser-induced fluorescence spectroscopy.

Authors:  Laura Marcu; Javier A Jo; Qiyin Fang; Thanassis Papaioannou; Todd Reil; Jian-Hua Qiao; J Dennis Baker; Julie A Freischlag; Michael C Fishbein
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

8.  Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography.

Authors:  Guillermo J Tearney; Hiroshi Yabushita; Stuart L Houser; H Thomas Aretz; Ik-Kyung Jang; Kelly H Schlendorf; Christopher R Kauffman; Milen Shishkov; Elkan F Halpern; Brett E Bouma
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

9.  Fluorescence analysis of biochemical constituents identifies atherosclerotic plaque with a thin fibrous cap.

Authors:  Koh Arakawa; Kikuo Isoda; Toshimitu Ito; Kei Nakajima; Toshio Shibuya; Fumitaka Ohsuzu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

10.  A dual-modality optical coherence tomography and fluorescence lifetime imaging microscopy system for simultaneous morphological and biochemical tissue characterization.

Authors:  Jesung Park; Javier A Jo; Sebina Shrestha; Paritosh Pande; Qiujie Wan; Brian E Applegate
Journal:  Biomed Opt Express       Date:  2010-07-16       Impact factor: 3.732

View more
  21 in total

1.  Deconvolution of fluorescence lifetime imaging microscopy by a library of exponentials.

Authors:  Daniel U Campos-Delgado; O Gutierrez Navarro; E R Arce-Santana; Alex J Walsh; Melissa C Skala; Javier A Jo
Journal:  Opt Express       Date:  2015-09-07       Impact factor: 3.894

2.  Blind deconvolution estimation of fluorescence measurements through quadratic programming.

Authors:  Daniel U Campos-Delgado; Omar Gutierrez-Navarro; Edgar R Arce-Santana; Melissa C Skala; Alex J Walsh; Javier A Jo
Journal:  J Biomed Opt       Date:  2015-07       Impact factor: 3.170

3.  Extended output phasor representation of multi-spectral fluorescence lifetime imaging microscopy.

Authors:  Daniel U Campos-Delgado; O Gutiérrez Navarro; E R Arce-Santana; Javier A Jo
Journal:  Biomed Opt Express       Date:  2015-05-13       Impact factor: 3.732

4.  Blind source separation of ex-vivo aorta tissue multispectral images.

Authors:  July Galeano; Sandra Perez; Yonatan Montoya; Deivid Botina; Johnson Garzón
Journal:  Biomed Opt Express       Date:  2015-04-06       Impact factor: 3.732

5.  Simultaneous morphological and biochemical endogenous optical imaging of atherosclerosis.

Authors:  Javier A Jo; Jesung Park; Paritosh Pande; Sebina Shrestha; Michael J Serafino; J de Jesus Rico Jimenez; Fred Clubb; Brian Walton; L Maximilian Buja; Jennifer E Phipps; Marc D Feldman; Jessie Adame; Brian E Applegate
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-02-26       Impact factor: 6.875

6.  Multimodal optical coherence tomography and fluorescence lifetime imaging with interleaved excitation sources for simultaneous endogenous and exogenous fluorescence.

Authors:  Sebina Shrestha; Michael J Serafino; Jesus Rico-Jimenez; Jesung Park; Xi Chen; Siqin Zhaorigetu; Brian L Walton; Javier A Jo; Brian E Applegate
Journal:  Biomed Opt Express       Date:  2016-08-01       Impact factor: 3.732

7.  Real-time visualization of two-photon fluorescence lifetime imaging microscopy using a wavelength-tunable femtosecond pulsed laser.

Authors:  Jiheun Ryu; Ungyo Kang; Jayul Kim; Hyunjun Kim; Jue Hyung Kang; Hyunjin Kim; Dae Kyung Sohn; Jae-Heon Jeong; Hongki Yoo; Bomi Gweon
Journal:  Biomed Opt Express       Date:  2018-06-28       Impact factor: 3.732

8.  Estimation of the number of fluorescent end-members for quantitative analysis of multispectral FLIM data.

Authors:  Omar Gutierrez-Navarro; Daniel U Campos-Delgado; Edgar R Arce-Santana; Kristen C Maitland; Shuna Cheng; Joey Jabbour; Bilal Malik; Rodrigo Cuenca; Javier A Jo
Journal:  Opt Express       Date:  2014-05-19       Impact factor: 3.894

9.  A fluorescence lifetime imaging classification method to investigate the collagen to lipid ratio in fibrous caps of atherosclerotic plaque.

Authors:  Jennifer E Phipps; Yinghua Sun; Michael C Fishbein; Laura Marcu
Journal:  Lasers Surg Med       Date:  2012-08-06       Impact factor: 4.025

10.  Direct frequency domain fluorescence lifetime imaging using field programmable gate arrays for real time processing.

Authors:  Michael J Serafino; Brian E Applegate; Javier A Jo
Journal:  Rev Sci Instrum       Date:  2020-03-01       Impact factor: 1.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.